Results 81 to 90 of about 9,670 (235)
Lexicon for Clonal Hematopoiesis in Liquid Biopsy
Clinical and Translational Science, Volume 19, Issue 1, January 2026.ABSTRACT Historically, clonal hematopoiesis (CH) has been recognized as a confounder of cell‐free DNA (cfDNA) testing. Recent evidence now demonstrates the role of CH as a risk factor in health, generating distinct sources of cfDNA that can be leveraged for liquid biopsy diagnostics.
Robert Tell +21 more
wiley +1 more source
Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas [PDF]
Journal of Pathology and Translational Medicine, 2016 Background: Recent studies have revealed that the splicing factor neuro-oncological ventral antigen 1 (NOVA1) is enriched in fibroblasts and accumulated T cells of tertiary lymphoid structures.
Eun Kyung Kim +5 more
doaj +1 more source
Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma [PDF]
, 2015 BACKGROUNDS: The role of interim PET/CT in peripheral T-cell lymphoma (PTCL) is less identified compared to other subtype of lymphoma. This study prospectively investigated the prognostic accuracy of sequential interim PET/CT using visual and ...
Byung Hyun Byun +14 more
core +1 more source
Cutaneous manifestations of angioimmunoblastic T-cell lymphoma [PDF]
Dermatology Online Journal, 2019 Angioimmunoblastic T-cell lymphoma (AITL) is a rare form of non-Hodgkin lymphoma often accompanied by autoimmune and paraneoplastic phenomena. Up to 50% of patients with AITL present with skin manifestations. This case series highlights two cases of AITL presenting with unusual cutaneous findings: one with a medium-vessel vasculitis and another with a ...
Hoskins, Sidney +5 more
openaire +4 more sources
Case Reports in Medicine, Volume 2026, Issue 1, 2026.Methotrexate (MTX) can cause MTX‐associated lymphoproliferative disorders (MTX‐LPDs) characterized by a T‐cell phenotype. Herein, we report an extremely rare case of MTX‐LPD with peripheral T‐cell lymphoma (PTCL) phenotype and lung and skeletal muscle involvement.
Katsunori Arai +9 more
wiley +1 more source
The Journal of Clinical Pharmacology, Volume 65, Issue 12, Page 1699-1711, December 2025.Abstract Valemetostat is a dual inhibitor of EZH2/1 approved in Japan for the treatment of relapsed/refractory (R/R) adult T–cell lymphoma/leukemia (ATLL) and R/R peripheral T–cell lymphoma (PTCL). It is administered orally once daily (QD) at 200 mg. Here, we present comprehensive population pharmacokinetic (PPK) and exposure–response (ER) analyses of ...
Hiroyuki Inoue +7 more
wiley +1 more source
Haematologica, 2007 Background and Objectives In the present paper we report that SAP, an intracytoplasmic molecule that is involved in cell signaling, is an immunohistologic marker for germinal center T cells in paraffin-embedded tissue.
Giovanna Roncador +11 more
doaj +1 more source
Diffuse Large B‐Cell Lymphoma Combined With Paroxysmal Nocturnal Hemoglobinuria: A Rare Case Report
Clinical Case Reports, Volume 13, Issue 11, November 2025.ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is a common hematological malignancy, and some patients may present with autoimmune hemolytic anemia (AIHA). However, the coexistence of DLBCL and paroxysmal nocturnal hemoglobinuria (PNH) is rare. PNH patients may develop myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML), but lymphomas are ...
Zhen zhen Liu +5 more
wiley +1 more source
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project [PDF]
, 2011 The International Peripheral T-cell Lymphoma Project is a collaborative effort to better understand peripheral T-cell lymphoma (PTCL). A total of 22 institutions submitted clinical and pathologic material on 1314 cases.
Armitage J.O. +20 more
core +1 more source